ArticleInvestigative ophthalmology & visual science2016

Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.

Tuhina Prasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.